UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dual antiviral therapy in haematological patients with protracted SARS‐CoV‐2 infection

British journal of haematology, 2023-06, Vol.201 (6), p.e62-e65

2023

Volltextzugriff (PDF)

Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper

Clinical microbiology and infection, 2017-12, Vol.23 (12), p.935-940

2017

Volltextzugriff (PDF)

IL28B polymorphisms, IP‐10 and viral load predict virological response to therapy in chronic hepatitis C

Alimentary pharmacology & therapeutics, 2011-05, Vol.33 (10), p.1162-1172

2011

Volltextzugriff (PDF)

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV‐infected adults

HIV medicine, 2008-02, Vol.9 (2), p.82-88

2008

Volltextzugriff (PDF)

Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV‐positive persons version 9.0

HIV medicine, 2018-05, Vol.19 (5), p.309-315

2018

Volltextzugriff (PDF)

Prophylaxis and treatment of hepatitis B in immunocompromised patients

Digestive and liver disease, 2007-05, Vol.39 (5), p.397-408

2007

Volltextzugriff (PDF)

Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV‐positive persons

HIV medicine, 2016-02, Vol.17 (2), p.83-88

2016

Volltextzugriff (PDF)

Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare

European review for medical and pharmacological sciences, 2021-12, Vol.25 (24), p.7985

2021

Volltextzugriff (PDF)

Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients in Italy between 1997 and 2015

Clinical microbiology and infection, 2018-04, Vol.24 (4), p.422-427

2018

Volltextzugriff (PDF)

Letter: sustained virological response and liver healing

Alimentary pharmacology & therapeutics, 2017-04, Vol.45 (8), p.1171-1173

2017

Volltextzugriff (PDF)

Letter: sorafenib hepatotoxicity may be enhanced during treatment of advanced hepatocellular carcinoma in HIV‐infected patients

Alimentary pharmacology & therapeutics, 2013-12, Vol.38 (11-12), p.1414-1416

2013

Volltextzugriff (PDF)

Genotype 3 infection in DAA era: reports of a real life Northern Italy network for viral hepatitis after 2 years by the start

Journal of hepatology, 2017, Vol.66 (1), p.S536-S536

2017

Volltextzugriff (PDF)

Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe

Clinical microbiology and infection, 2015-11, Vol.21 (11), p.1027-1032

2015

Volltextzugriff (PDF)

HCV infection: pathogenesis, clinical manifestations and therapy

Clinical and experimental rheumatology, 2008-01, Vol.26 (1 Suppl 48), p.S39

2008

Volltextzugriff (PDF)

Safety and efficacy of Ombitasvir, Paritaprevir/Ritonavir and Dasabuvir with or without ribavirin in chronic hepatitis C patients receiving opioid substitution therapy: a pooled analysis across 12 clinical trials

Journal of hepatology, 2017, Vol.66 (1), p.S514-S514

2017

Volltextzugriff (PDF)

The old patient in DAA era: real life reports on 5925 patients from the Lombardy HCV Network

Journal of hepatology, 2017, Vol.66 (1), p.S536-S537

2017

Volltextzugriff (PDF)

First Outbreak of Pneumocystis jirovecii Pneumonia in Heart Transplantation Recipients

The Journal of heart and lung transplantation, 2017-04, Vol.36 (4), p.S88-S89

2017

Volltextzugriff (PDF)

LP39 : Implications of baseline HCVRNA level and intrapatient viral load variability on OBV/PTV/R + DSV 12-week treatment outcomes

Journal of hepatology, 2015-04, Vol.62, p.S283-S283

2015

Volltextzugriff (PDF)

Safety and Efficacy of Directly Acting Antivirals in 2432 HCV Patients with Advanced Fibrosis: An Interim Analysis of the Lombardia Regional Network for Viral Hepatitis

Journal of hepatology, 2016, Vol.64 (2), p.S213-S213

2016

Volltextzugriff (PDF)

High SVR rates with eight and twelve weeks of pangenotypic glecaprevir/pibrentasvir: integrated efficacy and safety analysis of genotype 1–6 patients without cirrhosis

Journal of hepatology, 2017, Vol.66 (1), p.S721-S721

2017

Volltextzugriff (PDF)

Predictors of access and response to DAA in a cohort of human immunodeficiency virus/hepatitis C virus co-infected patients in Italy

Journal of hepatology, 2017, Vol.66 (1), p.S288-S288

2017

Volltextzugriff (PDF)

Ultrasound scanning in infants with biliary atresia: the different implications of biliary tract features and liver echostructure

Ultraschall in der Medizin, 2013-10, Vol.34 (5), p.463-467

2013

Volltextzugriff (PDF)

Diagnostic and therapeutic approaches of mixed cryoglobulinemia in PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort

Journal of hepatology, 2017, Vol.66 (1), p.S535-S535

2017

Volltextzugriff (PDF)

Evolution and Determinants of the Prevalence of HCV Infection and Hcv Genotype Distribution among Hivinfected Patients Entering in Care between 1997–2015 in Italy: Data from a Prospective Nationwide Cohort (ICONA)

Journal of hepatology, 2016, Vol.64 (2), p.S608-S608

2016

Volltextzugriff (PDF)

Genotype 3 infection in DAA era: Reports of a real life Northern Italy Network for viral hepatitis after 2 years by the start

Digestive and liver disease, 2017-02, Vol.49 (1), p.e68-e68

2017

Volltextzugriff (PDF)

1 – 25 von 497

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(480)
Mit Volltextzugriff
(448)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Dual antiviral therapy in haematological patients with protracted SARS‐CoV‐2 infection

Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper

IL28B polymorphisms, IP‐10 and viral load predict virological response to therapy in chronic hepatitis C

European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of chronic hepatitis B and C coinfection in HIV‐infected adults

Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV‐positive persons version 9.0

Prophylaxis and treatment of hepatitis B in immunocompromised patients

Essentials from the 2015 European AIDS Clinical Society (EACS) guidelines for the treatment of adult HIV‐positive persons

Host factors and history of SARS-CoV-2 infection impact the reactogenicity of BNT162b2 mRNA vaccine: results from a cross-sectional survey on 7,014 workers in healthcare

Evolution of the prevalence of hepatitis C virus infection and hepatitis C virus genotype distribution in human immunodeficiency virus-infected patients in Italy between 1997 and 2015

Letter: sustained virological response and liver healing

Letter: sorafenib hepatotoxicity may be enhanced during treatment of advanced hepatocellular carcinoma in HIV‐infected patients

Genotype 3 infection in DAA era: reports of a real life Northern Italy network for viral hepatitis after 2 years by the start

Differences in the availability of diagnostics and treatment modalities for chronic hepatitis B across Europe

HCV infection: pathogenesis, clinical manifestations and therapy

Safety and efficacy of Ombitasvir, Paritaprevir/Ritonavir and Dasabuvir with or without ribavirin in chronic hepatitis C patients receiving opioid substitution therapy: a pooled analysis across 12 clinical trials

The old patient in DAA era: real life reports on 5925 patients from the Lombardy HCV Network

First Outbreak of Pneumocystis jirovecii Pneumonia in Heart Transplantation Recipients

LP39 : Implications of baseline HCVRNA level and intrapatient viral load variability on OBV/PTV/R + DSV 12-week treatment outcomes

Safety and Efficacy of Directly Acting Antivirals in 2432 HCV Patients with Advanced Fibrosis: An Interim Analysis of the Lombardia Regional Network for Viral Hepatitis

High SVR rates with eight and twelve weeks of pangenotypic glecaprevir/pibrentasvir: integrated efficacy and safety analysis of genotype 1–6 patients without cirrhosis

Predictors of access and response to DAA in a cohort of human immunodeficiency virus/hepatitis C virus co-infected patients in Italy

Ultrasound scanning in infants with biliary atresia: the different implications of biliary tract features and liver echostructure

Diagnostic and therapeutic approaches of mixed cryoglobulinemia in PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort

Evolution and Determinants of the Prevalence of HCV Infection and Hcv Genotype Distribution among Hivinfected Patients Entering in Care between 1997–2015 in Italy: Data from a Prospective Nationwide Cohort (ICONA)

Genotype 3 infection in DAA era: Reports of a real life Northern Italy Network for viral hepatitis after 2 years by the start

Suchergebnisse filtern